3 S&P 500 Stocks We’re Skeptical OfThe S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...
2 Profitable Stocks with Impressive Fundamentals and 1 We Turn DownEven if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs PeersAs the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a...
The Top 5 Analyst Questions From Revvity’s Q1 Earnings CallRevvity’s first quarter results were well received by the market, as the company delivered stronger-than-expected organic growth and margins. Management attr...
3 Cash-Producing Stocks That Concern UsGenerating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
RVTY Q1 2026 Deep Dive: Portfolio Pruning and AI Investments Shape OutlookLife sciences company Revvity (
NYSE:RVTY) fell short of the market’s revenue expectations in Q1 CY2026, but sales rose 9.3% year on year to $686.9 million. T...
Why Is Revvity (RVTY) Stock Rocketing Higher TodayWhat Happened? Shares of life sciences company Revvity (
NYSE:RVTY) jumped 7.3% in the morning session after its first-quarter 2026 results surpassed Wall Str...
Revvity (NYSE:RVTY) Beats Q1 CY2026 Sales ExpectationsLife sciences company Revvity (
NYSE:RVTY) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 7% year on year to $711.1 million....
Revvity (NYSE:RVTY) Surprises With Q1 CY2026 SalesLife sciences company Revvity (
NYSE:RVTY) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 7% year on year to $711.1 milli...
Revvity Earnings: What To Look For From RVTYLife sciences company Revvity (
NYSE:RVTY) will be reporting earnings this Tuesday before market hours. Here’s what you need to know. Revvity beat analysts’ r...
3 Reasons to Avoid RVTY and 1 Stock to Buy InsteadRevvity currently trades at $94.26 per share and has shown little upside over the past six months, posting a small loss of 1.5%. The stock also fell short of...
Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To KnowWhat Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener...
3 S&P 500 Stocks with Warning SignsThe S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
Research Tools & Consumables Stocks Q4 Results: Benchmarking Revvity (NYSE:RVTY)As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry,...
Research Tools & Consumables Stocks Q4 Results: Benchmarking Revvity (NYSE:RVTY)The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To KnowWhat Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...
